VaxThera Achieves LEED® Gold Certification for Its Manufacturing Facility, Reinforcing Its Commitment to Sustainability
With a design focused on water and energy efficiency, VaxThera has achieved LEED Gold certification, validated by GBCI, marking a milestone that endorses its commitment to environmental performance and the well-being of people.. Medellín, February 2026 — VaxThera, a Colombian biotechnology company located in Rionegro, announces that it has obtained LEED® Gold certification for its […]
VaxThera and Hetero announce strategic alliance to expand access to high-cost biologic therapies
Collaboration begins with three monoclonal antibodies and establishes a pathway toward technology transfer and local production in Colombia for Latin America MEDELLÍN, Colombia. VaxThera S.A.S., a Colombian biotechnology company, and Hetero Biopharma Limited, an Hetero Group Company, a global pharmaceutical company with established expertise in biosimilars, announced a strategic alliance to expand timely and equitable […]
VaxThera and Codagenix Partner to Advance a Next Generation Yellow Fever Vaccine
Medellín, Colombia, and Farmingdale, Nueva York, September 16th 2026. VaxThera S.A.S., a Colombian biotechnology company developing and manufacturing vaccines and advanced biological products (“VaxThera”), and Codagenix Inc., a clinical-stage biotechnology company pioneering synthetic biology-based vaccines (“Codagenix”), today announced an agreement on terms for VaxThera to exclusively license Codagenix’s yellow fever vaccine candidate, Syn17D-YF (CDX-470). Under […]
EIB, European Commission and VaxThera boost Latin America’s vaccine capacity by up to 250 million doses a year
The European Investment Bank (EIB), in partnership with the European Commission, is providing a €15 million venture loan to VaxThera, a Colombian biotechnology company developing, manufacturing and commercialising vaccines and biopharmaceutical products. The deal is being announced in New York on the margins of the 81st session of the United Nations General Assembly. This is […]
VaxThera and Serum Institute of India Announce a Strategic Collaboration to Strengthen Vaccine Development and Health Security in Colombia
Medellín, Colombia VaxThera SAS (www.vaxthera.com), a Colombian-based biotechnology company, announced a strategic collaboration with Serum Institute of India (SII), a Cyrus Poonawalla group company and the world’s largest vaccine manufacturer, to strengthen vaccine manufacturing and health security in Colombia. This collaboration represents a historic step forward for Colombia. Together, VaxThera and the Serum Institute of […]
VaxThera, GC Biopharma and RIGHT Foundation Advance Influenza Vaccine Technology Transfer in Colombia
The project brings together international funding, proven vaccine expertise and local capabilities to strengthen vaccine manufacturing in Colombia and Latin America. VaxThera S.A.S., GC Biopharma and the Research Investment for Global Health Technology Foundation, known as RIGHT Foundation, announced a collaboration to advance the transfer of influenza vaccine manufacturing technology to Colombia. Supported by funding […]
